Mednet Logo

Do you ever treat cervical nodes above the standard supraclavicular field for breast cancer patients?

For breast cancer patients receiving adjuvant breast/chest wall RT + RNI, do you ever treat cervical nodes above the standard supraclavicular field (e.g., level II/III/V) when CT/MRI/PET is suspicious but biopsy is negative or non-diagnostic? If yes, do you extend elective coverage and/or boost the dominant node, and what findings push you to treat as oligometastatic M1 instead? For example, in a patient with ypN3a after NAC/ALND with an enhancing 1.6 cm ipsilateral SCV node and additional suspicious level II/III/V nodes on CT, PET read as reactive; FNA scant/atypical, core/excisional bx deemed too high risk. What would be your field design and dose/fx recommendations?
5 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · New York University School of Medicine
Answered on

In the setting of biopsy-proven supraclavicular or cervical nodal disease, I do extend my fields cranially to include these nodes. I typically include the entire neck level based on head and neck contouring atlases and extend the cranial border at least 1 cm superior to the highest node. If nodes ar...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Varian Medical Systems/Allegheny health network
Answered on

I generally follow the principle to treat one level above and lateral to the involvement. So, if medial s/c is positive (level 4 neck node) would include adjoining level 3 (cranial) and level 5 (lateral s/c). So, for the case described, a large nodal burden based on the index of suspicion would incl...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Dana-Farber Cancer Institute
Answered on

I similarly agree with the previous answers and would share that sometimes what radiologists are calling cervical lymph nodes on their formal read would be encompassed by our traditional supraclavicular contours, and/or the cranial extent to cover the suspicious and/or involved node(s) would not mea...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · UNC School of Medicine
Answered on

Good question, thanks for asking.

Yes. There are certainly many clinical situations where extending the superior border further superior (compared to our standard) is very reasonable; e.g., when there is suspected or proven, supraclavicular nodal disease. It is important to remember that our boundar...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Cedars-Sinai Medical Center
Answered on

I agree with and follow the same approach and technique as Dr. @Dr. First Last has described.

Join for free or sign in to see the full answer